Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
16-2
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Classification
advertisement
Classification List
1 General aspects
0
1.1
Epidemiology
14
1.2
Population genetics
1
1.3
Pathogenesis
2
1.4
Quality of life
3
1.5
Glaucomas as cause of blindness
1
1.6
Prevention and screening
7
2 Anatomical structures in glaucoma
0
2.1
Conjunctiva
7
2.2
Cornea
14
2.3
Sclera
7
2.4
Anterior chamber angle
3
2.5 Meshwork
0
2.5.1
Trabecular meshwork
11
2.5.2
Schlemms canal
1
2.5.3 Scleral outlet channels
0
2.6 Aqueous humor dynamics
0
2.6.1
Production
2
2.6.2
Outflow
2
2.6.2.1
Trabecular meshwork
2
2.6.2.2
Uveoscleral
1
2.6.3
Compostion
5
2.7 Episcleral veins and venous pressure
0
2.8
Iris
8
2.9
Ciliary body
2
2.10 Lens
0
2.11 Vitreous body
0
2.12
Choroid, peripapillary choroid, peripapillary atrophy
8
2.13
Retina and retinal nerve fibre layer
27
2.14
Optic disc
23
2.15
Optic nerve
4
2.16
Chiasma and retrochiasmal central nervous system
6
2.17
Stem cells
1
2.20 Other
0
3 Laboratory methods
0
3.1 Microscopy
0
3.2
Electron microscopy
1
3.3
Immunohistochemistry
4
3.4 Molecular genetics
0
3.4.1 Linkage studies
0
3.4.2
Gene studies
34
3.5
Molecular biology incl. SiRNA
14
3.6
Cellular biology
39
3.7
Biochemistry
14
3.8
Pharmacology
7
3.9
Pathophysiology
14
3.10
Immunobiology
2
3.11 Pharmacogenetics
0
3.12
Proteomics
1
3.13 In vivo imaging
0
3.13.1 Laser Scanning
0
3.13.1.1 Confocal Scanning Laser Ophthalmoscopy
0
3.13.1.2 Confocal Scanning Laser Polarimetry
0
3.13.2 Optical Coherence Tomography
0
3.13.2.1 Anterior Segment
0
3.13.2.2 Posterior Segment
0
3.13.3
RGC Imaging
1
3.13.4 Other
0
3.20 Other
0
4 Tissue culture of ocular cells
0
5 Experimental glaucoma; animal models
0
5.1
Rodent
18
5.2
Primates
5
5.3
Other
7
6
Clinical examination methods
1
6.1 Intraocular pressure measurement; factors affecting IOP
0
6.1.1
Devices, techniques
11
6.1.2
Fluctuation, circadian rhythms
9
6.1.3
Factors affecting IOP
17
6.2 Tonography, aqueous flow measurement (see also 2.6)
0
6.3 Biomicroscopy (slitlamp)
0
6.3.1
Anterior segment
1
6.3.2 Posterior segment
0
6.4
Gonioscopy
3
6.5
Ophthalmoscopy
2
6.6 Visual field examination and other visual function tests
0
6.6.1 Conventional manual
0
6.6.2
Automated
38
6.6.3
Special methods (e.g. color, contrast, SWAP etc.)
12
6.7
Electro-ophthalmodiagnosis
10
6.8 Photography
0
6.8.1
Anterior segment
2
6.8.2
Posterior segment
8
6.9 Computerized image analysis
0
6.9.1 Laser scanning
0
6.9.1.1
Confocal Scanning Laser Ophthalmoscopy
15
6.9.1.2
Confocal Scanning Laser Polarimetry
4
6.9.2 Optical coherence tomography
0
6.9.2.1
Anterior
4
6.9.2.2
Posterior
36
6.9.5
Other
3
6.10 Fluorescein (ICG) angiography
0
6.10.1 Anterior segment
0
6.10.2 Posterior segment
0
6.11
Bloodflow measurements
15
6.12
Ultrasonography and ultrasound biomicroscopy
2
6.13
Provocative tests
2
6.19
Telemedicine
4
6.20
Progression
16
6.30
Other
5
8 Refractive errors in relation to glaucoma
0
8.1
Myopia
7
8.2 Hypermetropia
0
8.3 Contact lenses
0
8.4
Refractive surgical procedures
1
8.5 Other
0
9 Clinical forms of glaucomas
0
9.1 Developmental glaucomas
0
9.1.1
Congenital glaucoma, Buphthalmos
15
9.1.2
Juvenile glaucoma
15
9.1.3
Syndromes of Axenfeld, Rieger, Peters, aniridia
4
9.1.4 Other
0
9.2 Primary open angle glaucomas
0
9.2.1
Ocular hypertension
2
9.2.2
Other risk factors for glaucoma
7
9.2.3
Open angle glaucoma with elevated IOP
1
9.2.4
Normal pressure glaucoma
12
9.3 Primary angle closure glaucomas
0
9.3.1
Acute primary angle closure glaucoma (pupillary block)
10
9.3.2
Chronic primary angle closure glaucoma (pupillary block)
2
9.3.3 Plateau iris syndrome
0
9.3.4
Primary angle closure suspect
2
9.3.5
Primary angle closure
10
9.3.10 Other
0
9.4 Glaucomas associated with other ocular and systemic disorders
0
9.4.1
Steroid-induced glaucoma
2
9.4.2 Glaucomas associated with disorders of the cornea, conjunctiva, sclera
0
9.4.2.1
Iridocorneal endothelial syndrome (ICE, incl. irisatrophy)
2
9.4.2.2 Posterior polymorphous dystrophy
0
9.4.2.3 Fuchs' endothelial dystrophy
0
9.4.2.5
Other
1
9.4.3 Glaucomas associated with disorders of the iris and ciliary body
0
9.4.3.1
Pigmentary glaucoma
3
9.4.3.5 Other
0
9.4.4 Glaucomas associated with disorders of the lens
0
9.4.4.1
Exfoliation syndrome
16
9.4.4.2
Glaucomas associated with cataracts
1
9.4.4.3
Glaucomas associated with lens dislocation
2
9.4.4.5
Other
1
9.4.5 Glaucomas associated with disorders of the retina, choroid and vitreous
0
9.4.5.1
Neovascular glaucoma
4
9.4.5.5
Other
7
9.4.6
Glaucomas associated with inflammation, uveitis
8
9.4.7
Glaucomas associated with ocular trauma
2
9.4.8
Glaucomas associated with intraocular tumors
3
9.4.9 Glaucomas associated with elevated episcleral venous pressure
0
9.4.10
Glaucomas associated with hemorrhage
5
9.4.11 Glaucomas following intraocular surgery
0
9.4.11.1 Ciliary block (malignant) glaucoma
0
9.4.11.2
Glaucomas in aphakia and pseudophakia
7
9.4.11.3 Epithelial, fibrous, and endothelial proliferation
0
9.4.11.4
Glaucomas associated with corneal surgery
2
9.4.11.5
Glaucomas associated with vitreoretinal surgery
2
9.4.15
Glaucoma in relation to systemic disease
25
9.4.20 Other
0
10
Differential diagnosis e.g. anterior and posterior ischemic optic neuropathy
7
11
Medical treatment
1
11.1
General management, indication
4
11.2
Cholinergic drugs
2
11.3 Adrenergic drugs
0
11.3.1 Epinephrine
0
11.3.2 Thymoxamine, dapiprazole
0
11.3.3
Apraclonidine, brimonidine
5
11.3.4
Betablocker
7
11.3.5 Other
0
11.4
Prostaglandins
14
11.5
Carbonic anhydrase inhibitors
1
11.5.1 Systemic
0
11.5.2 Topical
0
11.6 Osmotic treatment
0
11.7 Treatment of bloodflow
0
11.8
Neuroprotection
15
11.9
Gene therapy
1
11.13 Combination therapy
0
11.13.1 Betablocker and pilocarpine
0
11.13.2
Betablocker and carbon anhydrase inhibitor
2
11.13.3 Betablocker and brimonidine
0
11.13.4
Betablocker and prostaglandin
4
11.13.5
Other
1
11.14
Investigational drugs; pharmacological experiments
11
11.15
Other drugs in relation to glaucoma
7
11.16
Vehicles, delivery systems, pharmacokinetics, formulation
17
11.17
Cooperation with medical therapy e.g. persistency, compliance, adherence
10
11.20 Other
0
12
Surgical treatment
1
12.1 General management, indication
0
12.2
Laser iridotomy
6
12.3 Laser iridoplasty
0
12.4
Laser trabeculoplasty and other laser treatment of the angle
6
12.7
Surgical iridectomy
1
12.8
Filtering surgery
1
12.8.1
Without tube implant
14
12.8.2
With tube implant or other drainage devices
14
12.8.3
Non-perforating
1
12.8.4 Using laser
0
12.8.5 Other
0
12.8.10
Woundhealing antifibrosis
9
12.8.11
Complications, endophthalmitis
6
12.9
Trabeculotomy, goniotomy
2
12.10
Cyclodestruction
5
12.11 Cyclodialysis
0
12.12 Cataract extraction
0
12.12.1 Intracapsular
0
12.12.2 Extracapsular
0
12.12.3
Phacoemulsification
2
12.14 Combined cataract extraction and glaucoma surgery
0
12.14.1 Intracapsular
0
12.14.2 Extracapsular
0
12.14.3
Phacoemulsification
4
12.15 Capsulotomy
0
12.16 Vitrectomy
0
12.17
Anesthesia
2
12.20
Other
1
13 Therapeutic prognosis and outcome
0
13.1
Prognostic factors
1
13.2 Outcome
0
13.2.1 IOP
0
13.2.2 Visual field
0
13.2.2.1 Progression
0
13.2.2.2
Improvement
2
13.2.3 Other
0
14
Costing studies; pharmacoeconomics
6
15
Miscellaneous
23
Issue
16-2
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-2 (2024)
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement